Semaglutide (or Ozempic) is not an exception
By far, the most commonly reported side effects of using semaglutide are gastrointestinal upsets - nausea, vomiting, diarrhea, constipation, heartburn, and stomach pain
Nausea affects approximately 32% of patients, but this typically occurs early in treatment and resolves within weeks
That is no longer the only option. The European Medicines Agency (EMA) has officially backed the use of Novo Nordisk's Wegovy, a groundbreaking medication primarily known for weight loss, to aid Recent research published on Forbes has shed light on the effectiveness of Mounjaro (tirzepatide), a prominent medication used for weight loss and diabetes
What hygiene practices are recommended to reduce UTI risks on Semaglutide
Wegovy is a GLP-1 receptor agonist used for weight loss